87558504 - ROCK

Information

  • Trademark
  • 87558504
  • Serial Number
    87558504
  • Registration Number
    5484283
  • Filing Date
    August 07, 2017
    9 years ago
  • Registration Date
    June 05, 2018
    8 years ago
  • Transaction Date
    April 16, 2025
    a year ago
  • Status Date
    March 20, 2025
    a year ago
  • Published for Opposition Date
    March 20, 2018
    8 years ago
  • Location Date
    March 20, 2025
    a year ago
  • Status Code
    705
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    AIKENS, RONALD
  • Attorney Docket Number
    8167-001T
    Attorney Name
    Shauna M. Wertheim
  • Owners
Mark Drawing Code
4
Mark Identification
ROCK
Case File Statements
  • B00001: In the statement, Page 2 line 2, "REG. NO. 01706865" should be deleted, and REG. NO. 017068685 should be inserted.
  • GS0051: [ Pharmaceutical and veterinary preparations; biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for medical or veterinary purposes; biological and biochemical preparations in form of bifunctional or multifunctional proteins with binding affinity to immune cells, in particular with binding affinity to T cells and natural killer (NK) cells, in particular for the subsequent targeting of cancer cells; biological and biochemical preparations for diagnostic and therapeutic use, in particular in form of antibodies, antibody derivatives, binding proteins and peptides; biological and biochemical preparations in form of antibodies, antibody derivatives, binding proteins and peptides for use within the framework of experimental and medical or veterinary assays ]
  • GS0011: [ Biological and biochemical preparations, in particular in form of antibodies, antibody derivatives, binding proteins and peptides for laboratory and experimentation purposes, in particular for conducting experimental assays, other than for medical or veterinary purposes ]
  • GS0441: Medical services, in particular in the field of immunotherapy, in particular in the field of immuno-oncology; medical services in the field of virology; medical services in the field of antiinfectives; medical services in the field of neurodegenerative diseases; medical services in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodies, antibody derivatives, binding proteins and peptides; medical services in the field of immunotherapy by means of activating or modulating innate and adaptive immunity, in particular in the field of immuno-oncology
  • GS0421: Scientific and technological services, research and design in the field of immuno-therapy, in particular in the field of immuno-oncology; scientific and technological services, research and design in the field of virology; scientific and technological services, research and design in the field of antiinfectives; scientific and technological services, research and design in the field of neurodegenerative diseases; scientific and technological services, research and design in the field of autoimmune diseases; in particular all of the aforesaid services related to the use of antibodies, antibody derivatives, binding proteins and peptides; scientific and technological services, research and design in the field of immunotherapy by means of activating or modulating innate and adaptive immunity, in particular in the field of immune-oncology; industrial analysis and research services
Case File Event Statements
  • 11/8/2017 - 9 years ago
    4 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 8/10/2017 - 9 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 8/10/2017 - 9 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/8/2017 - 9 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/8/2017 - 9 years ago
    5 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 11/8/2017 - 9 years ago
    10 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Type: GNS3
  • 11/8/2017 - 9 years ago
    6 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 11/8/2017 - 9 years ago
    7 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 11/8/2017 - 9 years ago
    8 - SUSPENSION LETTER WRITTEN Type: CNSL
  • 11/8/2017 - 9 years ago
    9 - LETTER OF SUSPENSION E-MAILED Type: GNSL
  • 3/20/2018 - 8 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 1/12/2018 - 8 years ago
    11 - TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED Type: ERSI
  • 1/25/2018 - 8 years ago
    12 - ASSIGNED TO LIE Type: ALIE
  • 1/27/2018 - 8 years ago
    13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 1/27/2018 - 8 years ago
    14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 1/29/2018 - 8 years ago
    15 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 2/2/2018 - 8 years ago
    16 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR
  • 2/15/2018 - 8 years ago
    17 - ELECTRONIC RECORD REVIEW COMPLETE Type: FIXD
  • 2/28/2018 - 8 years ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/5/2018 - 8 years ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 10/6/2023 - 3 years ago
    28 - TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Type: REAP
  • 3/20/2018 - 8 years ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 6/19/2018 - 8 years ago
    22 - TEAS SECTION 7 REQUEST RECEIVED Type: ES7R
  • 7/9/2018 - 8 years ago
    23 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 7/16/2018 - 8 years ago
    24 - CORRECTION UNDER SECTION 7 - PROCESSED Type: COC.
  • 6/5/2023 - 3 years ago
    25 - COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Type: REM1
  • 10/6/2023 - 3 years ago
    29 - ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Type: ARAA
  • 10/6/2023 - 3 years ago
    27 - APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Type: CHAN
  • 10/6/2023 - 3 years ago
    26 - TEAS CHANGE OF OWNER ADDRESS RECEIVED Type: COAR
  • 10/6/2023 - 3 years ago
    30 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 3/20/2025 - a year ago
    34 - NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED Type: NA85
  • 11/26/2024 - a year ago
    31 - TEAS SECTION 8 & 15 RECEIVED Type: E815
  • 3/20/2025 - a year ago
    32 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 3/20/2025 - a year ago
    33 - REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. Type: C15P